氨甲环酸治疗月经过多：一项双盲试验。
Treatment of menorrhagia with tranexamic acid. A double-blind trial.
作者信息
Callender S T, Warner G T, Cope E
出版信息
Br Med J. 1970 Oct 24;4(5729):214-6. doi: 10.1136/bmj.4.5729.214.
Abstract
In a double-blind trial tranexamic acid (Cyclokapron) 1 g. four times a day for the first four days of menstruation, significantly decreased menstrual blood loss in women with menorrhagia for which no organic cause had been found. No difference in side-effects was noted between the active and placebo treatment.
摘要
在一项双盲试验中，对于未发现器质性病因的月经过多女性，在月经的头四天每天四次服用1克氨甲环酸（凝血酸），可显著减少月经量。活性治疗组和安慰剂治疗组在副作用方面未发现差异。
相似文献
1
Treatment of menorrhagia with tranexamic acid. A double-blind trial.氨甲环酸治疗月经过多：一项双盲试验。
Br Med J. 1970 Oct 24;4(5729):214-6. doi: 10.1136/bmj.4.5729.214.
2
Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.氨甲环酸（AMCA）对宫内节育器所致月经过多的影响。
J Reprod Med. 1970 Oct;5(4):154-61.
3
[Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
Lakartidningen. 1971 Aug 11;68(33):3685-91.
4
Tranexamic acid: a review of its use in the management of menorrhagia.氨甲环酸：关于其在月经过多治疗中应用的综述。
Drugs. 2003;63(13):1417-33. doi: 10.2165/00003495-200363130-00008.
5
Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.抗纤溶治疗与抗前列腺素治疗对使用宫内节育器女性月经过多减少情况的比较。
Br J Obstet Gynaecol. 1983 Jan;90(1):78-83. doi: 10.1111/j.1471-0528.1983.tb06751.x.
6
An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia.氟比洛芬与氨甲环酸治疗特发性月经过多的客观评价。
Acta Obstet Gynecol Scand. 1988;67(7):645-8. doi: 10.3109/00016348809004279.
7
Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.经期月经过多的治疗：氨甲环酸、甲芬那酸和氨甲苯酸的随机对照试验
BMJ. 1996 Sep 7;313(7057):579-82. doi: 10.1136/bmj.313.7057.579.
8
A double blind study of the effect of tranexamic acid in essential menorrhagia.氨甲环酸治疗功能性月经过多疗效的双盲研究。
Bull Soc R Belge Gynecol Obstet. 1968;38(5):385-90.
9
Antifibrinolytics in women with menorrhagia.抗纤溶药物在月经过多妇女中的应用。
Thromb Res. 2011 Feb;127 Suppl 3:S113-5. doi: 10.1016/S0049-3848(11)70030-5.
10
Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161).使用新型抗纤溶药物（卡比2161）减少特发性月经过多女性的月经量
Br J Obstet Gynaecol. 1995 Nov;102(11):913-7. doi: 10.1111/j.1471-0528.1995.tb10881.x.
引用本文的文献
1
Current and Emerging Treatment Options for Uterine Fibroids.子宫肌瘤的当前和新兴治疗选择。
Drugs. 2023 Dec;83(18):1649-1675. doi: 10.1007/s40265-023-01958-6. Epub 2023 Nov 3.
2
Tranexamic Acid (TXA) for the Hemostatic Treatment of Post-Partum Hemorrhage (PPH): What Key Points Have We Learnt After All These Years?氨甲环酸用于产后出血（PPH）的止血治疗：这么多年我们学到了哪些关键点？
J Clin Med. 2023 Oct 6;12(19):6385. doi: 10.3390/jcm12196385.
3
Variation of outcome reporting in studies of interventions for heavy menstrual bleeding: a systematic review.月经过多干预研究中结果报告的差异：一项系统评价
Facts Views Vis Obgyn. 2022 Sep;14(3):205-218. doi: 10.52054/FVVO.14.3.030.
4
Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.干预重度月经过多；Cochrane 综述和网络荟萃分析概述。
Cochrane Database Syst Rev. 2022 May 31;5(5):CD013180. doi: 10.1002/14651858.CD013180.pub2.
5
Tranexamic acid evidence and controversies: An illustrated review.氨甲环酸的证据与争议：图文并茂的综述
Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12546. doi: 10.1002/rth2.12546. eCollection 2021 Jul.
6
Damage control resuscitation.损伤控制复苏
Clin Exp Emerg Med. 2020 Mar;7(1):5-13. doi: 10.15441/ceem.19.089. Epub 2020 Mar 31.
7
The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients.氨甲环酸的多种作用：氨甲环酸在医疗和手术患者中的临床应用概述。
Eur J Haematol. 2020 Feb;104(2):79-87. doi: 10.1111/ejh.13348. Epub 2019 Dec 16.
8
Antifibrinolytics for heavy menstrual bleeding.用于月经过多的抗纤溶药物。
Cochrane Database Syst Rev. 2018 Apr 15;4(4):CD000249. doi: 10.1002/14651858.CD000249.pub2.
9
Heavy menstrual bleeding: work-up and management.月经过多：检查与管理
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):236-242. doi: 10.1182/asheducation-2016.1.236.
10
Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence.氨甲环酸用于子宫肌瘤的治疗：当前证据的系统评价
World J Clin Cases. 2014 Dec 16;2(12):893-8. doi: 10.12998/wjcc.v2.i12.893.
本文引用的文献
1
EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID (EPSILON-ACA) IN THE TREATMENT OF PROFUSE MENSTRUATION.
Acta Med Scand. 1965 Apr;177:445-57.
2
Menstrual blood loss--a population study. Variation at different ages and attempts to define normality.月经失血——一项人群研究。不同年龄段的差异及对正常范围的界定尝试。
Acta Obstet Gynecol Scand. 1966;45(3):320-51. doi: 10.3109/00016346609158455.
3
A whole-body counter for clinical measurements utilizing the 'shadow shield' technique.
Phys Med Biol. 1966 Jan;11(1):83-94. doi: 10.1088/0031-9155/11/1/307.
4
A double blind study of the effect of tranexamic acid in essential menorrhagia.
Thromb Diath Haemorrh. 1968 Dec 31;20(3):583-7.
5
Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation.用ε-氨基己酸治疗月经过多。一项双盲研究。
Acta Obstet Gynecol Scand. 1965;44(3):467-73. doi: 10.3109/00016346509155880.
6
Measurement of blood loss by means of a whole-body counter.通过全身计数器测量失血量。
Br Med J. 1967 Oct 14;4(5571):86-8. doi: 10.1136/bmj.4.5571.86.
Zotero 插件